Skip to content
Study details
Enrolling now

A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors

University of California, Irvine
NCT IDNCT05836688ClinicalTrials.gov data as of Apr 2026
Target enrollment

250

Study length

about 4.8 years

Ages

18–39

Sex

Male only

Locations

1 site in CA

About this study

This trial is testing a new treatment called Goal-Focused Emotion-Regulation Therapy (GET) and Individual Supportive Listening for young adult testicular cancer survivors. The goal is to see if GET can help reduce distress symptoms, improve emotion regulation, and enhance stress-sensitive biomarkers in these patients.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Participate in Goal-Focused Emotion-Regulation Therapy (GET)
  • 2.Participate in Individual Supportive Listening
Primary goalChange in Hospital Anxiety and Depression Scale (HADS)

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low8%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Primary: Change in Hospital Anxiety and Depression Scale (HADS), Change in Systemic Pro-inflammatory Cytokine Levels (IL-6, IL-1ra, C-reactive Protein [CRP], sTNFαRII)

Body systems

Oncology